COVID-19 hasn’t disappeared, but the way we protect against it is shifting.
In late August, the FDA made an unusual move: it narrowed its approval for the COVID-19 vaccine to just two groups.
-
Approved: Adults 65+
-
Approved: Anyone 6 months and older with a high-risk condition
That’s a big change from previous years when nearly everyone over six months old was encouraged to get vaccinated.
This shift has caused confusion not only in the public but also within the medical community. Groups like the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists continue to recommend broader use, including for pregnant women and young children. Other organizations, like the Infectious Diseases Society of America, have strongly opposed the FDA’s narrower label. Typically, the FDA, medical societies, and public health groups are in alignment, so this kind of disconnect is rare — and it’s leading to mixed messages for the public.